Clinical Studies
Results

Clinical Studies
Results

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Pelham, Alabama
Phoenix, Arizona
Phoenix, Arizona
69 more locations... see details
Ends 3 years from now

Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

Oklahoma City, Oklahoma
Hadar, Nebraska
Shawnee, Kansas
9 more locations... see details
Ends 4 months from now
Page 1 of 1